首页> 外文OA文献 >North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study

【2h】

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study

机译：北中央癌症治疗组/联盟试验N08CA - 使用谷胱甘肽预防紫杉醇/卡铂诱导的周围神经病变：A相随机，双盲，安慰剂对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Alexis D. Leal; Rui Qin; Pamela J. Atherton; Paul Haluska; Robert J. Behrens; Charles H. Tiber; Patanit Watanaboonyakhet; Matthias Weiss; Paul T. Adams; Travis J. Dockter; Charles L. Loprinzi;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. North Central Cancer Treatment Group/Alliance trial N08CA - The use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study [J] . LealA.D., QinR., AthertonP.J., Cancer: A Journal of the American Cancer Society . 2014,第12期

机译：北部中部癌症治疗组/联合试验N08CA-谷胱甘肽在预防紫杉醇/卡铂引起的周围神经病变中的应用：一项3期随机，双盲，安慰剂对照研究
2. North Central Cancer Treatment Group/Alliance trial N08CA - The use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study [J] . LealA.D., QinR., AthertonP.J., Cancer: A Journal of the American Cancer Society . 2014,第12期

机译：北部中部癌症治疗组/联合试验N08CA-谷胱甘肽在预防紫杉醇/卡铂引起的周围神经病变中的应用：一项3期随机，双盲，安慰剂对照研究
3. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. [J] . Moraska AR, Sood A, Dakhil SR, Journal of Clinical Oncology . 2010,第23期

机译：长效哌醋甲酯治疗癌症相关疲劳的III期随机，双盲，安慰剂对照研究：北中部癌症治疗组NCCTG-N05C7试验。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Effect of Intranasal Insulin on Cognition and Emotional Processing in Individuals with Treatment-Resistant Major Depressive Disorder. [D] . Cha, Danielle Soh-Young. 2016

机译：一项随机，双盲，安慰剂对照的交叉试验评估了鼻内胰岛素对难治性重度抑郁症患者认知和情绪加工的影响。
6. NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized Double-Blind Placebo-Controlled Study [O] . Alexis D. Leal, Rui Qin, Pamela J. Atherton, -1

机译：NCCTG N08CA（联盟）：谷胱甘肽在预防紫杉醇/卡铂引起的周围神经病变中的应用：III期随机双盲安慰剂对照研究
7. Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial [O] . Moraska, Amanda R., Sood, Amit, Dakhil, Shaker R., 2010

机译：长效哌醋甲酯用于癌症相关疲劳的III期随机，双盲，安慰剂对照研究：北中部癌症治疗组NCCTG-N05C7试验

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study

著录项

相似文献

相关主题

期刊订阅